PB1739: ADVERSE EFFECTS OF ASPARAGINASE IN THE TREATMENT OF ACUTE LYMPHOBLASTIC LEUKEMIA

por Chenbah, Wafa, Sayed, Nesrine Ben, Regaieg, Haifa, Guermazi, Monia, Youssef, Yosra Ben, Bouslama, Emna, Zahra, Kmira, Khelif, Abderrahim
Publicado 2023

PB2069: ELTROMBOPAG WITH IMMUNO SUPPRESSIVE THERAPY IN SEVERE ACQUIRED APLASTIC ANEMIA IN CHILDREN AND ADOLESCENTS: A MONOCENTRIC EXPERIENCE

por Sayed, Nesrine Ben, Sassi, Nadia, Regaieg, Haifa, Aidli, Rim, Chenbah, Wafa, Ouni, Bouraoui, Zahra, Kmira, Youssef, Yosra Ben, Khelif, Abderrahim
Publicado 2023

PB2263: TOXICITY PROFILE OF SALVAGE CHEMOTHERAPY REGIMENS IN PATIENTS WITH RELAPSED/ REFRACTORY HODGKIN LYMPHOMA.

por Zahra, Kmira, Sghaier, Rihab Ben, Guermazi, Monia, Chenbah, Wafa, Sayed, Nesrine Ben, Zaier, Monia, Youssef, Yosra Ben, Regaieg, Haifa, Khelif, Abderrahim
Publicado 2023

PB2262: PROGNOSTIC FACTORS IN PATIENTS WITH RELAPSED/REFRACTORY HODGKINN LYMPHOMA

por Zahra, Kmira, Sghaier, Rihab Ben, Guermazi, Monia, Sayed, Nesrine Ben, Ines, Ouahchi, Zaier, Monia, Youssef, Yosra Ben, Regaieg, Haifa, Khelif, Abderrahim
Publicado 2023

PB2556: MEGALOBLASTIC ANEMIA: EPIDEMIOLOGICAL, CLINICAL, AND ETIOLOGICAL PROFILE: ABOUT 200 CASES.

por Zahra, Kmira, Hasnaoui, Zeineb, Chenbah, Wafa, Ncibi, Seif, Ines, Ouahchi, Sayed, Nesrine Ben, Zaier, Monia, Youssef, Yosra Ben, Regaieg, Haifa, Khelif, Abderrahim
Publicado 2023